Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001059093 | SCV001223700 | pathogenic | PMM2-congenital disorder of glycosylation | 2023-02-27 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 854121). This variant has not been reported in the literature in individuals affected with PMM2-related conditions. This variant is present in population databases (rs201855351, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Trp187*) in the PMM2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PMM2 are known to be pathogenic (PMID: 19862844). |
Baylor Genetics | RCV001059093 | SCV004205307 | likely pathogenic | PMM2-congenital disorder of glycosylation | 2023-12-31 | criteria provided, single submitter | clinical testing |